discodermolide and bryostatin-1

discodermolide has been researched along with bryostatin-1* in 2 studies

Reviews

1 review(s) available for discodermolide and bryostatin-1

ArticleYear
Targeting apoptosis pathways by natural compounds in cancer: marine compounds as lead structures and chemical tools for cancer therapy.
    Cancer letters, 2013, May-28, Volume: 332, Issue:2

    Natural compounds derived from marine organisms have shown a wide variety of anti-tumor effects and a lot of attention has been drawn to further development of the isolated compounds. A vast quantity of individual chemical structures from different organisms has shown a variety of apoptosis inducing mechanisms in a variety of tumor cells. The bis-steroidal cephalostatin 1 for example, induces apoptosis via activation of caspases whereas the polyketide discodermolide inhibits cell growth by binding to and stabilizing microtubule and salisporamide A, the product of an actinobacterial strain, is an inhibitor of the proteasome. This great variety of mechanisms of action can help to overcome the multitude of resistances exhibited by different tumor specimens. Products from marine organisms and their synthetic derivates are therefore an important source for new therapeutics for single agent or combined therapy with other chemotherapeutics to support the struggle against cancer.

    Topics: Alkaloids; Alkanes; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Aquatic Organisms; Biological Products; Bryostatins; Carbamates; Cell Proliferation; Depsipeptides; Dioxoles; Drug Screening Assays, Antitumor; Humans; Lactones; Macrolides; Microtubules; Models, Chemical; Neoplasms; Phenanthrolines; Phenazines; Proteasome Endopeptidase Complex; Pyrones; Pyrroles; Quinolines; Spiro Compounds; Steroids; Tetrahydroisoquinolines; Thiazoles; Trabectedin

2013

Other Studies

1 other study(ies) available for discodermolide and bryostatin-1

ArticleYear
Chemistry. The renaissance of natural products as drug candidates.
    Science (New York, N.Y.), 2005, Oct-21, Volume: 310, Issue:5747

    Topics: Alkanes; Anti-Infective Agents; Antineoplastic Agents; Biological Products; Bryostatins; Carbamates; Clinical Trials as Topic; Combinatorial Chemistry Techniques; Drug Design; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Evolution, Molecular; Furans; Genetic Engineering; Ketones; Lactones; Macrolides; Molecular Structure; Pyrones; Structure-Activity Relationship

2005